Aptose Biosciences Stock Performance
| APS Stock | CAD 4.36 0.34 7.23% |
Aptose Biosciences holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -33.54, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Aptose Biosciences are expected to decrease by larger amounts. On the other hand, during market turmoil, Aptose Biosciences is expected to outperform it. Use Aptose Biosciences semi variance, and the relationship between the maximum drawdown and accumulation distribution , to analyze future returns on Aptose Biosciences.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Aptose Biosciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Aptose Biosciences displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:15 | Last Split Date 2023-06-06 |
1 | Aptose Biosciences announces clinical data on tuspetinib - TipRanks | 12/09/2024 |
2 | Aptose Biosciences Initiates TUSCANY Trial for Frontline AML Therapy - TipRanks | 01/09/2025 |
3 | Aptose Biosciences Establishes 25M Equity Facility - TipRanks | 02/13/2025 |
4 | Aptose Biosciences Inc. Short Interest Update - MarketBeat | 02/28/2025 |
| Begin Period Cash Flow | 37 M |
Aptose |
Aptose Biosciences Relative Risk vs. Return Landscape
If you would invest 25.00 in Aptose Biosciences on December 1, 2024 and sell it today you would earn a total of 411.00 from holding Aptose Biosciences or generate 1644.0% return on investment over 90 days. Aptose Biosciences is generating 16.1415% of daily returns assuming 128.7069% volatility of returns over the 90 days investment horizon. Simply put, majority of traded equity instruments are less risky than Aptose on the basis of their historical return distribution, and most equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Aptose Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aptose Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aptose Biosciences, and traders can use it to determine the average amount a Aptose Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1254
| Best Portfolio | Best Equity | APS | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 128.71 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average Aptose Biosciences is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aptose Biosciences by adding it to a well-diversified portfolio.
Aptose Biosciences Fundamentals Growth
Aptose Stock prices reflect investors' perceptions of the future prospects and financial health of Aptose Biosciences, and Aptose Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aptose Stock performance.
| Return On Equity | -6.94 | ||||
| Return On Asset | -1.42 | ||||
| Current Valuation | (697.89 K) | ||||
| Shares Outstanding | 2.14 M | ||||
| Price To Earning | (1.85) X | ||||
| Price To Book | 68.22 X | ||||
| EBITDA | (52.27 M) | ||||
| Net Income | (51.21 M) | ||||
| Cash And Equivalents | 36.37 M | ||||
| Cash Per Share | 0.64 X | ||||
| Total Debt | 1.01 M | ||||
| Debt To Equity | 5.00 % | ||||
| Current Ratio | 11.27 X | ||||
| Book Value Per Share | (14.04) X | ||||
| Cash Flow From Operations | (44.59 M) | ||||
| Earnings Per Share | (125.61) X | ||||
| Market Capitalization | 9.35 M | ||||
| Total Asset | 12.99 M | ||||
| Retained Earnings | (515.54 M) | ||||
| Working Capital | (3.38 M) | ||||
About Aptose Biosciences Performance
By examining Aptose Biosciences' fundamental ratios, stakeholders can obtain critical insights into Aptose Biosciences' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Aptose Biosciences is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (4.53) | (4.31) | |
| Return On Capital Employed | 20.67 | 21.70 | |
| Return On Assets | (4.53) | (4.31) | |
| Return On Equity | 15.89 | 16.68 |
Things to note about Aptose Biosciences performance evaluation
Checking the ongoing alerts about Aptose Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aptose Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aptose Biosciences is way too risky over 90 days horizon | |
| Aptose Biosciences appears to be risky and price may revert if volatility continues | |
| Aptose Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (51.21 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Aptose Biosciences has accumulated about 36.37 M in cash with (44.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.64. | |
| Latest headline from news.google.com: Aptose Biosciences Inc. Short Interest Update - MarketBeat |
- Analyzing Aptose Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aptose Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Aptose Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aptose Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aptose Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aptose Biosciences' stock. These opinions can provide insight into Aptose Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptose Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.